Clear Impact logo P

Vermont Medicaid

Logo

Budget Information

What We Do

Who We Serve

How We Impact

Measures

Most Recent Period
Current Actual Value
Current Target Value
Current Trend
Baseline % Change
PM
HP CAHPS
MSC: Medical Assistance with Smoking & Tobacco Use Cessation: Advising to Quit
MY 2024
77.5%
2
1%
PM
HP CAHPS
MSC: Medical Assistance with Smoking & Tobacco Use Cessation: Discussing Cessation Medications
MY 2024
52.9%
4
-14%
PM
HP CAHPS
MSC: Medical Assistance with Smoking & Tobacco Use Cessation: Discussing Cessation Strategies
MY 2024
50.3%
1
-4%
PM
HP CAHPS
MSC: Medical Assistance with Smoking and Tobacco Use Cessation: Percentage of survey respondents who indicate that they smoke cigarettes or use tobacco products every day or some days
MY 2024
23.9%
1
-44%
PM
ACS-MY
IET: Engagement of Alcohol & Other Drug Dependence Treatment - Age 18+ (ACS-MY)
MY 2023
19.9%
1
35%
PM
ACS-MY
IET: Initiation of Alcohol & Other Drug Dependence Treatment - Age 18+ (ACS-MY)
MY 2023
41.0%
1
-3%
PM
ACS-MY
FUH: Follow Up After Hospitalization for Mental Illness within 30 Days - Age 18+ (ACS-MY)
MY 2023
65.2%
2
-13%
PM
ACS-MY
FUH: Follow Up After Hospitalization for Mental Illness within 7 Days - Age 18+ (ACS-MY)
MY 2023
45.9%
2
-23%
PM
ACS-MY
CHL: Chlamydia Screening in Women - Age 21-24 (ACS-MY)
MY 2023
55.4%
1
-2%
PM
ACS-MY
CCS: Cervical Cancer Screening - Age 21-64 (ACS-MY)
MY 2023
50.0%
1
-4%
PM
ACS-MY
BCS: Breast Cancer Screening - Age 50-74 (ACS-MY)
MY 2023
51.0%
2
-9%
PM
ACS-MY
SSD: Diabetes Scrng for People w/ Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications - Age 18-64 (ACS-MY)
MY 2024
77.0%
4
13%
PM
ACS-MY
SAA: Adherence to Antipsychotics for Individuals with Schizophrenia - Age 18+ (ACS-MY)
MY 2024
77.2%
1
44%
PM
ACS-MY
PQI-15: Asthma in Younger Adults Admission Rate - Age18-39 (ACS-MY)
MY 2023
1.3
1
-73%
PM
ACS-MY
PQI-08: Heart Failure Admission Rate - Age 18+ (ACS-MY)
MY 2023
10.9
1
213%
PM
ACS-MY
PQI-05: Chronic Obstructive Pulmonary Disease or Asthma in Older Adults Admission Rate - Age 40+ (ACS-MY)
MY 2023
17.6
1
-24%
PM
ACS-MY
PQI-01: Diabetes Short Term Complications Admission Rate - Age 18+ (ACS-MY)
MY 2023
10.2
2
3%
PM
ACS-MY
PCR: Plan All-Cause Readmissions Rate - Age 18-64 (ACS-MY)
MY 2023
9.7%
1
-21%
PM
ACS-MY
FVA: Flu Vaccinations for Adults Age 18-64 (ACS-MY)
MY 2023
32.3%
1
-33%
PM
ACS-MY
AMM: Antidepressant Medication Management Continuation Phase - Age 18+ (ACS-MY)
MY 2024
63.5%
3
35%
PM
ACS-MY
AMM: Antidepressant Medication Management Acute Phase - Age 18+ (ACS-MY)
MY 2024
78.7%
2
21%
PM
ACS-MY
OHD: Use of Opioids at High Dosage - Age 18+ (ACS-MY)
MY 2022
10.8%
3
-19%
PM
ACS-MY
FUA: Follow Up After ED Visit for Alcohol or Other Drug Dependence within 7 Days - Age 18+ (ACS-MY)
MY 2024
38.4%
1
22%
PM
ACS-MY
FUM: Follow Up After ED Visit for Mental Illness within 30 Days - Age 18+ (ACS-MY)
MY 2024
69.7%
2
-10%
PM
ACS-MY
FUM: Follow Up After ED Visit for Mental Illness within 7 Days - Age 18+ (ACS-MY)
MY 2024
58.5%
2
-6%
PM
ACS-MY
FUA: Follow Up After ED Visit for Alcohol or Other Drug Dependence within 30 Days - Age 18+ (ACS-MY)
MY 2024
56.9%
2
18%
PM
ACS-MY
OUD: Use of Pharmacotherapy for Opioid Use Disorder - Age 18-64 (ACS-MY)
MY 2024
90.6%
2
0%
PM
ACS-MY
AMR: Asthma Medication Ratio - Age 19-64 (ACS-MY)
MY 2023
54.7%
2
0%
PM
ACS-MY
CBP: Controlling High Blood Pressure - Age 18+ (ACS-MY)
MY 2023
58.4%
3
17%
PM
ACS-MY
CCP: Contraceptive Care for Postpartum Women; MMEC 3 days - Age 21-44 (ACS-MY)
MY 2023
15.4%
2
10%
PM
ACS-MY
CCP: Contraceptive Care for Postpartum Women; MMEC 90 days - Age 21-44 (ACS-MY)
MY 2023
54.0%
3
74%
PM
ACS-MY
CCP: Contraceptive Care for Postpartum Women; LARC 3 days - Age 21-44 (ACS-MY)
MY 2023
2.5%
1
-51%
PM
ACS-MY
CCP: Contraceptive Care for Postpartum Women; LARC 90 days - Age 21-44 (ACS-MY)
MY 2023
19.1%
1
12%
PM
ACS-MY
CCW: Contraceptive Care for All Women; MMEC - Age 21-44 (ACS-MY)
MY 2023
25.0%
1
41%
PM
ACS-MY
CCW: Contraceptive Care for All Women; LARC - Age 21-44 (ACS-MY)
MY 2023
5.1%
2
-43%
PM
ACS-MY
COB: Concurrent Use of Opioids and Benzodiazepines - Age 18+ (ACS-MY)
MY 2023
16.9%
1
11%
PM
ACS-MY
HBD: Hemoglobin A1c Control for Patients with Diabetes in Poor Control (>9.0%) - Age 18-75 (ACS-MY)
MY 2023
44.5%
1
-7%
PM
ACS-MY
PPC: Postpartum Care Rate (ACS-MY)
MY 2023
80.3%
1
23%
PM
ACS-MY
AAB: Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis - Age 18-64 (ACS-MY)
MY 2023
44.1%
2
8%
PM
ACS-MY
HPCMI: Diabetes Care for People with Serious Mental Illness: Hemoglobin A1c (HbA1c) Poor Control (>9%) (ACS-MY)
MY 2024
46.7%
2
-5%
PM
ACS-MY
HBD: Hemoglobin A1c Control for Patients with Diabetes in Control (<8.0%) - Age 18-75 (ACS-MY)
MY 2023
46.2%
1
1%
PM
ACS-MY
COL: Colorectal Cancer Screening - Age 46-75 (ACS-MY)
MY 2023
31.0%
1
9%
PM
ACS-MY
CDF: Screening for Depression and Follow Up Plan - Age 18+ (ACS-MY)
MY 2024
0.0%
1
-100%
Powered by Clear Impact

Clear Impact Suite is an easy-to-use, web-based software platform that helps your staff collaborate with external stakeholders and community partners by utilizing the combination of data collection, performance reporting, and program planning.

Scorecard Container Measure Action Actual Value Target Value Tag S A m/d/yy m/d/yyyy